ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 135 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,054,000 | -20.8% | 16,619 | -64.8% | 0.42% | -34.8% |
| Q3 2019 | $1,330,000 | -46.5% | 47,186 | -49.7% | 0.65% | -38.8% |
| Q2 2019 | $2,486,000 | +30.2% | 93,796 | -9.9% | 1.06% | +25.1% |
| Q1 2019 | $1,909,000 | +37.0% | 104,056 | -7.2% | 0.84% | +10.9% |
| Q4 2018 | $1,393,000 | -45.1% | 112,124 | -15.3% | 0.76% | -25.9% |
| Q3 2018 | $2,538,000 | +74.8% | 132,379 | +24.0% | 1.03% | +45.0% |
| Q2 2018 | $1,452,000 | – | 106,795 | – | 0.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
| Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
| JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
| WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
| M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
| Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
| Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
| Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
| SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
| Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |